Fecal Microbiota Transplant No Aid for Parkinson Disease
At six months, no significant changes seen in Movement Disorder Society Unified Parkinson’s Disease Rating Scale scores versus placebo
Population-Level Interventions Cost-Effective for Reducing Risk for Dementia
Interventions could reduce risk factors for dementia, resulting in cost-savings and gain in quality-adjusted life years
Pharmacist Prescribing Can Reduce Stroke Risk in A-Fib Patients
Findings seen for pharmacist prescribing compared with usual care in older adults at high risk for stroke
Plasma Biomarkers of Alzheimer Neuropathy Linked to Dementia Risk
Significant associations seen for all Alzheimer disease plasma biomarkers in late life with late-life dementia
Most Traditional Cardiovascular Risk Factors Not Linked to Migraine
Current smoking, diabetes mellitus, higher fasting glucose level all linked to lower prevalence of migraine in women
Amyloid Probability Score 2 Has High Diagnostic Accuracy for Alzheimer Disease
Diagnostic accuracy 73 percent for dementia specialists compared with 91 percent using the APS2
Cognitive Impairment More Often Experienced by Patients With RA
RA patients with moderate-to-high inflammation also have lower mean values in MoCA and lower executive function scores
Robot-Assisted Gait Training Beneficial for Children With Cerebral Palsy
Overground gait training with wearable robot improves gross motor function and gait pattern
Being at Eye Level May Benefit Clinician-Patient Interaction
Eye-level communication more effective compared with standing at the bedside of inpatients
Stroke Certification Less Likely in the Most Disadvantaged Communities
Hospitals located in most disadvantaged communities least likely to have adoption of any stroke certification
